GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » Long-Term Debt

Guangzhou Wondfo Biotech Co (SZSE:300482) Long-Term Debt : ¥566 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Guangzhou Wondfo Biotech Co Long-Term Debt?

Guangzhou Wondfo Biotech Co's Long-Term Debt for the quarter that ended in Jun. 2024 was ¥566 Mil.

Guangzhou Wondfo Biotech Co's quarterly Long-Term Debt increased from Dec. 2023 (¥553 Mil) to Mar. 2024 (¥560 Mil) and increased from Mar. 2024 (¥560 Mil) to Jun. 2024 (¥566 Mil).

Guangzhou Wondfo Biotech Co's annual Long-Term Debt increased from Dec. 2021 (¥511 Mil) to Dec. 2022 (¥532 Mil) and increased from Dec. 2022 (¥532 Mil) to Dec. 2023 (¥553 Mil).

Guangzhou Wondfo Biotech Co Long-Term Debt Historical Data

The historical data trend for Guangzhou Wondfo Biotech Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Wondfo Biotech Co Long-Term Debt Chart

Guangzhou Wondfo Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 489.40 510.69 532.49 552.84

Guangzhou Wondfo Biotech Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 545.50 546.09 552.84 559.60 566.34

Guangzhou Wondfo Biotech Co  (SZSE:300482) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Guangzhou Wondfo Biotech Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Guangzhou Wondfo Biotech Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Wondfo Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » Long-Term Debt
Comparable Companies
SHSE:688139 SHSE:600587 SHSE:688351 SHSE:600055 SHSE:688389 SHSE:688016 SHSE:688212 SZSE:301363 SHSE:601089 SZSE:300869 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 8, Lizhishan Road, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510641
Website
http://www.wondfo.com.cn
Guangzhou Wondfo Biotech Co Ltd manufactures medical diagnostic tests. Its products include immunodiagnostic rapid test kits, including fertility, which include pregnancy HCG, ovulation LH, and others. The company's products are used in a clinical test, field test, and personal health management, among others.
Executives
He Xiao Wei Director
Kang Ke Ren Executives
Yu Fang Xia Executives
Li Wen Mei Directors, executives
Wang Ji Hua Director
Peng Zhong Xiong Executives
Zhao Ya Ping Executives
Luo Hong Supervisors
Zhou Yong Supervisors

Guangzhou Wondfo Biotech Co Headlines

No Headlines